Literature DB >> 11435562

Gag-Pol supplied in trans is efficiently packaged and supports viral function in human immunodeficiency virus type 1.

M K Hill1, C W Hooker, D Harrich, S M Crowe, J Mak.   

Abstract

The intracellular trafficking and subsequent incorporation of Gag-Pol into human immunodeficiency virus type 1 (HIV-1) remains poorly defined. Gag-Pol is encoded by the same mRNA as Gag and is generated by ribosomal frameshifting. The multimerization of Gag and Gag-Pol is an essential step in the formation of infectious viral particles. In this study, we examined whether the interaction between Gag and Gag-Pol is initiated during protein translation in order to facilitate the trafficking and subsequent packaging of Gag-Pol into the virion. A conditional cotransfection system was developed in which virion formation required the coexpression of two HIV-1-based plasmids, one that produces both Gag and Gag-Pol and one that only produces Gag-Pol. The Gag-Pol proteins were either immunotagged with a His epitope or functionally tagged with a mutation (K65R) in reverse transcriptase that is associated with drug resistance. Gag-Pol packaging was assessed to determine whether the Gag-Pol incorporated into the virion was preferentially packaged from the plasmid that expressed both Gag and Gag-Pol or whether it could be packaged from either plasmid. Our data show that translation of Gag and Gag-Pol from the same mRNA is not critical for virion packaging of the Gag-Pol polyprotein or for viral function.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11435562      PMCID: PMC114410          DOI: 10.1128/JVI.75.15.6835-6840.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Form, function, and use of retroviral gag proteins.

Authors:  J W Wills; R C Craven
Journal:  AIDS       Date:  1991-06       Impact factor: 4.177

2.  Characterization of ribosomal frameshifting in HIV-1 gag-pol expression.

Authors:  T Jacks; M D Power; F R Masiarz; P A Luciw; P J Barr; H E Varmus
Journal:  Nature       Date:  1988-01-21       Impact factor: 49.962

3.  Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells.

Authors:  D Gheysen; E Jacobs; F de Foresta; C Thiriart; M Francotte; D Thines; M De Wilde
Journal:  Cell       Date:  1989-10-06       Impact factor: 41.582

4.  Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity.

Authors:  M Shehu-Xhilaga; S M Crowe; J Mak
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

5.  Effects of mutations within the 3' orf open reading frame region of human T-cell lymphotropic virus type III (HTLV-III/LAV) on replication and cytopathogenicity.

Authors:  E Terwilliger; J G Sodroski; C A Rosen; W A Haseltine
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

6.  Requirements for incorporation of Pr160gag-pol from human immunodeficiency virus type 1 into virus-like particles.

Authors:  A J Smith; N Srinivasakumar; M L Hammarskjöld; D Rekosh
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

7.  Association of murine leukemia virus pol with virions, independent of Gag-Pol expression.

Authors:  G L Buchschacher; L Yu; F Murai; T Friedmann; A Miyanohara
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

8.  (-)-2'-deoxy-3'-thiacytidine is a potent, highly selective inhibitor of human immunodeficiency virus type 1 and type 2 replication in vitro.

Authors:  J A Coates; N Cammack; H J Jenkinson; A J Jowett; M I Jowett; B A Pearson; C R Penn; P L Rouse; K C Viner; J M Cameron
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

9.  The nonmyristylated Pr160gag-pol polyprotein of human immunodeficiency virus type 1 interacts with Pr55gag and is incorporated into viruslike particles.

Authors:  J Park; C D Morrow
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

10.  Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells.

Authors:  J C Burns; T Friedmann; W Driever; M Burrascano; J K Yee
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

View more
  13 in total

1.  C-Terminal HIV-1 Transframe p6* Tetrapeptide Blocks Enhanced Gag Cleavage Incurred by Leucine Zipper Replacement of a Deleted p6* Domain.

Authors:  Fu-Hsien Yu; Kuo-Jung Huang; Chin-Tien Wang
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

Review 2.  HIV Genome-Wide Protein Associations: a Review of 30 Years of Research.

Authors:  Guangdi Li; Erik De Clercq
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-29       Impact factor: 11.056

3.  The conformation of the mature dimeric human immunodeficiency virus type 1 RNA genome requires packaging of pol protein.

Authors:  M Shehu-Xhilaga; M Hill; J A Marshall; J Kappes; S M Crowe; J Mak
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

4.  Perturbing HIV-1 Ribosomal Frameshifting Frequency Reveals a cis Preference for Gag-Pol Incorporation into Assembling Virions.

Authors:  Bayleigh E Benner; James W Bruce; Jacob R Kentala; Magdalena Murray; Jordan T Becker; Pablo Garcia-Miranda; Paul Ahlquist; Samuel E Butcher; Nathan M Sherer
Journal:  J Virol       Date:  2021-10-13       Impact factor: 6.549

5.  A single amino acid substitution in HIV-1 reverse transcriptase significantly reduces virion release.

Authors:  Chien-Cheng Chiang; Shiu-Mei Wang; Yen-Yu Pan; Kuo-Jung Huang; Chin-Tien Wang
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

6.  The dimer initiation sequence stem-loop of human immunodeficiency virus type 1 is dispensable for viral replication in peripheral blood mononuclear cells.

Authors:  M K Hill; M Shehu-Xhilaga; S M Campbell; P Poumbourios; S M Crowe; J Mak
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

7.  Human immunodeficiency virus type 1 protease regulation of tat activity is essential for efficient reverse transcription and replication.

Authors:  Ann Apolloni; C William Hooker; Johnson Mak; David Harrich
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

8.  Labeling of multiple HIV-1 proteins with the biarsenical-tetracysteine system.

Authors:  Cândida F Pereira; Paula C Ellenberg; Kate L Jones; Tara L Fernandez; Redmond P Smyth; David J Hawkes; Marcel Hijnen; Valérie Vivet-Boudou; Roland Marquet; Iain Johnson; Johnson Mak
Journal:  PLoS One       Date:  2011-02-11       Impact factor: 3.240

9.  Placement of leucine zipper motifs at the carboxyl terminus of HIV-1 protease significantly reduces virion production.

Authors:  Yen-Yu Pan; Shiu-Mei Wang; Kuo-Jung Huang; Chien-Cheng Chiang; Chin-Tien Wang
Journal:  PLoS One       Date:  2012-03-01       Impact factor: 3.240

10.  Processing sites in the human immunodeficiency virus type 1 (HIV-1) Gag-Pro-Pol precursor are cleaved by the viral protease at different rates.

Authors:  Steve C Pettit; Jeffrey N Lindquist; Andrew H Kaplan; Ronald Swanstrom
Journal:  Retrovirology       Date:  2005-11-01       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.